2nd EACR Conference on Radiation Break-through: From DNA Damage Responses to Precision Cancer Therapy
OVERVIEW
2nd European Association for Cancer Research (EACR) Conference on Radiation Break-through: From DNA Damage Responses to Precision Cancer Therapy is organized by European Association for Cancer Research (EACR) and will be held during Mar 12 - 14, 2018 at Wolfson College, Oxford, Oxford, England, United Kingdom.
Target Audience :
This conference aims to bring together cancer scientists and physicians from different disciplines with an interest in DNA damage signaling and repair, the response of cells and tissues to photon and proton irradiation, as well as related fields of cancer research spanning from basic to clinical research. We envision ample opportunities for early-stage basic cancer researchers and young physicians to present their work to the international community and to meet experts in the field in an inspiring informal atmosphere to share research findings and to establish or strengthen collaborations.
Conference Overview :
The DNA damage response is critical to the maintenance of the genome and also determines the efficacy of DNA-damaging cancer therapies including radiotherapy and chemotherapy. Aberrant DNA damage response and DNA repair are frequent in malignant tumours and can sustain tumour development. At the same time, they offer tumour-specific vulnerabilities that can be exploited in the clinic. Understanding how the DNA damage response is regulated by genetic or metabolic alterations and microenvironmental cues is thus crucial to the design of therapeutic strategies based DNA damage induction, photon and particle irradiation, as well as to minimizing resistance to radiotherapy and chemotherapy.
This is the second EACR conference focused on this topic. Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of the DNA damage response and associated tumour cell-specific alterations in cancer initiation, progression and precision cancer therapy.
Topics to be Covered :
• Mechanistic insights into the cellular responses to DNA damage and genomic stability
• Therapeutic exploitation of defective DNA damage response and repair
• New treatment approaches combining radiotherapy with targeted drugs or immunotherapy
• Radiobiology biomarkers for precision radiotherapy
Additional details will be posted as soon as they are available.
Target Audience :
This conference aims to bring together cancer scientists and physicians from different disciplines with an interest in DNA damage signaling and repair, the response of cells and tissues to photon and proton irradiation, as well as related fields of cancer research spanning from basic to clinical research. We envision ample opportunities for early-stage basic cancer researchers and young physicians to present their work to the international community and to meet experts in the field in an inspiring informal atmosphere to share research findings and to establish or strengthen collaborations.
Conference Overview :
The DNA damage response is critical to the maintenance of the genome and also determines the efficacy of DNA-damaging cancer therapies including radiotherapy and chemotherapy. Aberrant DNA damage response and DNA repair are frequent in malignant tumours and can sustain tumour development. At the same time, they offer tumour-specific vulnerabilities that can be exploited in the clinic. Understanding how the DNA damage response is regulated by genetic or metabolic alterations and microenvironmental cues is thus crucial to the design of therapeutic strategies based DNA damage induction, photon and particle irradiation, as well as to minimizing resistance to radiotherapy and chemotherapy.
This is the second EACR conference focused on this topic. Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of the DNA damage response and associated tumour cell-specific alterations in cancer initiation, progression and precision cancer therapy.
Topics to be Covered :
• Mechanistic insights into the cellular responses to DNA damage and genomic stability
• Therapeutic exploitation of defective DNA damage response and repair
• New treatment approaches combining radiotherapy with targeted drugs or immunotherapy
• Radiobiology biomarkers for precision radiotherapy
Additional details will be posted as soon as they are available.
KEY DATES
12 Mar, 2018
Event Start Date
14 Mar, 2018
Event End Date
SPECIALITIES
OncologyBiochemistry and Molecular GeneticsSUGGESTED HOTELS
CONFERENCE VENUE
Wolfson College, OxfordRELATED CONFERENCES & LIVE WEBINARS
Quick Links